Chune Ren

Chune Ren


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2023 in Apoptosis
Verified
Journal Article
Closed access
PDF file
JLJiayi Lu
Jiayi Lu
XLXi Ling
Xi Ling
YSYonghong Sun
Yonghong Sun
LLLu Liu
Lu Liu
LLLan Liu
Lan Liu
ZYzhenhai yu
zhenhai yu

1 April 2021 in Clinical and Translational Medicine
Verified
Journal Article
Open access
PDF file
CLChao Lu
Chao Lu
PQPengyun Qiao
Pengyun Qiao
YSYonghong Sun
Yonghong Sun
CRChune Ren
Chune Ren
ZYzhenhai yu
zhenhai yu
Background: Breast cancer (BC) is one of the most common female malignancies in the world. Chemotherapeutic resistance is the major cause of BC therapy failure, leading to tumor recurrence and metastasis. Studies have illustrated the close relationship between glycolysis and BC progression and drug resistance. The key glycolysis regulator, PFKFB3 makes a difference during BC progression and drug resistance. However, the mechanism remains to be unknown.Methods: Mass spectrometry analyses were used to found that PIM2 was a potential new binding protein of PFKFB3. Co‐immunoprecipitated and western blot were used to verify the interaction between PIM2 and PFKFB3 in BC and the molecular mechanism by which PIM2 phosphorylates PFKFB3 in regulating the protein function. PFKFB3 mutant forms were used to demonstrate the need for PFKFB3 in BC drug resistance.Results: We identified that PIM2 is a new binding protein of PFKFB3. We used biochemical methods to determine that PIM2 can directly bind and change the phosphorylation of PFKFB3 at Ser478 to enhance PFKFB3 protein stability through the ubiquitin‐proteasome pathway. Importantly, phosphorylation of PFKFB3 at Ser478 promoted glycolysis, BC cell growth, and paclitaxel resistance together with PIM2 in vitro and in vivo.Conclusion: Our study demonstrates that PIM2 mediates PFKFB3 phosphorylation thus regulates glycolysis and paclitaxel resistance to promote tumor progression in BC and provides preclinical evidence for targeting PFKFB3 as a new strategy in BC treatment to battle paclitaxel resistance.

9 June 2021 in Reproductive Biology and Endocrinology
Verified
Journal Article
Open access
PDF file
YWYixin Wang
Yixin Wang
JXJing Xiu
Jing Xiu
TYTingting Yang
Tingting Yang
CRChune Ren
Chune Ren
ZYzhenhai yu
zhenhai yu
Background: Endometriosis is a chronic hormonal inflammatory disease characterized by the presence of endometrial tissue outside the uterus. Endometriosis often causes infertility, which brings physical and mental pain to patients and their families. Methods: We examined the functions of heat shock factor 1 (HSF1) in endometriosis development through cell count assay, cell-scratch assay and clone formation experiments. We used quantitative real-time PCR (qRT-PCR) and Western blot (WB) to detect HSF1 expression. Glucose and lactate levels were determined using a glucose (GO) assay kit and a lactate assay kit. Furthermore, we used a HSF1 inhibitor-KRIBB11 to establish a mouse model of endometriosis. Results: Our data demonstrated that HSF1 promoted endometriosis development. Interestingly, HSF1 enhanced glycolysis via up-regulating PFKFB3 expression in endometriosis cells, which was a key glycolysis enzyme. Consistently, the HSF1 inhibitor KRIBB11 could abrogate endometriosis progression in vivo and in vitro. Conclusions: Findings indicate that HSF1 plays an important role in endometriosis development, which might become a new target for the treatment of endometriosis. Electronic supplementary material: Supplementary data are available.

14 October 2022 in iScience
Verified
Journal Article
Open access
XLXi Ling
Xi Ling
JLJiayi Lu
Jiayi Lu
XWXiaoyun Wang
Xiaoyun Wang
LLLan Liu
Lan Liu
LLLu Liu
Lu Liu
ZYzhenhai yu
zhenhai yu
Endometriosis is a common chronic condition characterized by abnormal growth of the endometrium outside the uterus. Heat shock transcription factor 1 (HSF1) is a significant regulator of the proteotoxic stress response and plays an essential role in developing endometriosis. However, the mechanisms regulating HSF1 protein stability in endometriosis remain unclear. Here, we demonstrate that OTUB1 interacts with HSF1 and promotes HSF1 protein stability through deubiquitination. In addition, OTUB1 enhances glycolysis and epithelial-mesenchymal transition of endometriosis cells, leading to promote proliferation, migration, and invasion of endometriosis cells. The progression of endometriosis is inhibited in an OTUB1-knockout mouse model. In summary, OTUB1 promotes the development of endometriosis by up-regulating HSF1. OTUB1/HSF1 axis may become a new therapeutic target for endometriosis.

9 October 2023 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
XLXi Ling
Xi Ling
LLLan Liu
Lan Liu
AJAifang Jiang
Aifang Jiang
XSXiaodan Shi
Xiaodan Shi
LLLu Liu
Lu Liu
ZYzhenhai yu
zhenhai yu

27 September 2024 in Frontiers of Medicine
Verified
Journal Article
Closed access
PDF file
JLJiayi Lu
Jiayi Lu
XWXiaoyun Wang
Xiaoyun Wang
XSXiaodan Shi
Xiaodan Shi
JJJunyi Jiang
Junyi Jiang
LLLan Liu
Lan Liu
ZYzhenhai yu
zhenhai yu